Press release
Catheter-Related Bloodstream Infections Market: Epidemiology, Treatments, and Key Players | DelveInsight
Catheter-Related Bloodstream Infections Market
Key companies in this space include Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, and Fresenius Medical Care. Therapies for catheter-related bloodstream infections, such as DEFENCATH and MINO-LOK, are anticipated to drive market growth over the coming years.
DelveInsight has released a comprehensive report titled "Catheter-Related Bloodstream Infections - Market Insights, Epidemiology, and Forecast to 2034", providing detailed insights into the disease, historical and projected epidemiology, and market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Discover about the Catheter-related bloodstream infections market report [https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Some of the key facts of the Catheter-related bloodstream infections Market Report:
*
As of May 2025, the FDA approved DefenCath (taurolidine and heparin), marking the first antimicrobial catheter lock solution in the U.S. to reduce catheter-related bloodstream infections (CRBSIs) in adults with kidney failure undergoing chronic hemodialysis via a central venous catheter.
*
Citius Pharmaceuticals acquired global rights to MINO-LOK from the University of Texas MD Anderson Cancer Center. MINO-LOK has received FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation (FTD), with patent protection until 2024 and formulation patents extending to 2036.
*
In November 2023, CorMedix's DEFENCATH gained FDA approval to treat CRBSIs in adult kidney failure patients on chronic hemodialysis. Approval in Europe and Japan could further expand its market reach.
*
In May 2024, Citius Pharmaceuticals reported positive topline results from its pivotal Phase III trial of MINO-LOK, which met its primary endpoint by significantly improving time to failure events compared to a clinician-directed anti-infective lock solution.
*
The full incidence, progression, and clinical burden of CRBSIs remain poorly understood, and the treatment pipeline is limited, with Citius Pharmaceuticals being the only developer with an active therapy. Rising CRBSI cases and the introduction of new treatments are expected to drive market growth in the coming years.
*
Leading companies-including Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, and Fresenius Medical Care-are actively exploring new therapies to enhance the CRBSI treatment landscape. Promising therapies include DEFENCATH, MINO-LOK, and others.
Catheter-related bloodstream infections Overview
Catheter-Related Bloodstream Infection (CRBSI), also known as catheter-related sepsis, occurs when bacteria enter the bloodstream via an intravenous catheter. It is among the most common, severe, and costly complications of central venous catheterization and is the leading cause of hospital-acquired bacteremia. CRBSIs can be caused by a variety of organisms, including coagulase-negative staphylococci, Staphylococcus aureus, enteric gram-negative bacilli, enterococci, streptococci, Pseudomonas, and others.
CRBSI is often suspected in patients with a central venous catheter who develop fever, chills, or unexplained hypotension without other apparent causes. Mild symptoms may include malaise and nausea, while severe cases can present with high fever accompanied by rigors, hypotension, vomiting, or altered mental status, even when the catheter exit site and tunnel appear normal on examination.
The catheter-related bloodstream infection report offers a comprehensive overview of CRBSI, covering its pathophysiology, diagnostic approaches, and a detailed treatment algorithm. It also includes a real-world patient case illustrating the journey from initial symptoms to diagnosis and through the full course of treatment.
Catheter-related bloodstream infections Market Outlook
When a catheter-related bloodstream infection (CRBSI) is suspected, clinical guidelines generally recommend removing the catheter first. If fever persists, antibiotic and antifungal therapies are typically initiated, often starting empirically. Commonly prescribed off-label antibiotics for CRBSI include daptomycin, vancomycin, cefazolin, ampicillin, ciprofloxacin, amikacin, and teicoplanin, while antifungals such as fluconazole and amphotericin B are also used off-label.
The treatment landscape for CRBSI is gradually evolving, with only a single pharmaceutical company currently advancing a novel therapy into late-stage development. Key players, including Citius Pharmaceuticals, are actively evaluating their lead candidates at various clinical stages to explore potential new treatments for CRBSI.
Discover how the Catheter-related bloodstream infections market [https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] is rising in the coming years
Catheter Related Bloodstream Infection Marketed Drugs
*
DEFENCATH: CorMedix
Catheter-related bloodstream infections Emerging Drugs
*
MINO-LOK: Citius Pharmaceuticals
Scope of the Catheter-related bloodstream infections Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Catheter-related bloodstream infections Companies: Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, and others
*
Key Catheter-related bloodstream infections Therapies: DEFENCATH, MINO-LOK, and others
*
Catheter-related bloodstream infections Therapeutic Assessment: Catheter-related bloodstream infections current marketed and Catheter-related bloodstream infections emerging therapies
*
Catheter-related bloodstream infections Market Dynamics: Catheter-related bloodstream infections market drivers and Catheter-related bloodstream infections market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Catheter-related bloodstream infections Unmet Needs, KOL's views, Analyst's views, Catheter-related bloodstream infections Market Access and Reimbursement
To know what's more in our Catheter-related bloodstream infections report, visit https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Key benefits of the Catheter-related bloodstream infections Market Report:
*
Catheter-related bloodstream infections market report covers a descriptive overview and comprehensive insight of the Catheter-related bloodstream infections Epidemiology and Catheter-related bloodstream infections market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan).
*
The Catheter-related bloodstream infections market report provides insights into the current and emerging therapies.
*
The Catheter-related bloodstream infections market report provides a global historical and forecasted market covering drug outreach in 7MM.
*
The Catheter-related bloodstream infections market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Catheter-related bloodstream infections market.
Got queries? Click here to know more about the Catheter-related bloodstream infections market Landscape [https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Catheter-related bloodstream infections Patient Share (%) Overview at a Glance
5. Catheter-related bloodstream infections Market Overview at a Glance
6. Catheter-related bloodstream infections Disease Background and Overview
7. Catheter-related bloodstream infections Epidemiology and Patient Population
8. Country-Specific Patient Population of Catheter-related bloodstream infections
9. Catheter-related bloodstream infections Current Treatment and Medical Practices
10. Unmet Needs
11. Catheter-related bloodstream infections Emerging Therapies
12. Catheter-related bloodstream infections Market Outlook
13. Country-Wise Catheter-related bloodstream infections Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Catheter-related bloodstream infections Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Catheter-related bloodstream infections Market Outlook 2034 [https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Related Reports:
Catheter-related bloodstream infections Pipeline Insights, DelveInsight
"Catheter-related bloodstream infections Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Catheter-related bloodstream infections market. A detailed picture of the Catheter-related bloodstream infections pipeline landscape is provided, which includes the disease overview and Catheter-related bloodstream infections treatment guidelines.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=catheterrelated-bloodstream-infections-market-epidemiology-treatments-and-key-players-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Catheter-Related Bloodstream Infections Market: Epidemiology, Treatments, and Key Players | DelveInsight here
News-ID: 4185407 • Views: …
More Releases from ABNewswire
Laparoscopic Devices Market Poised for Steady Growth Through 2032, Driven by Inn …
Laparoscopy Devices by Product Type, Application, End-User, and Geography is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of cancer such as gastrointestinal and colorectal cancer, growing adoption of minimally invasive surgeries across the globe, and growing advancement in Laparoscopy technology.
The global laparoscopic devices market was valued at USD 11.35 billion in 2023 and is expected to grow at a CAGR of…
Influenza A Market: Epidemiology, Therapies, Companies, DelveInsight | Cidara Th …
The influenza A market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM influenza A market size from 2020 to 2034. The report also covers current influenza A treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's potential.
Influenza A therapies, such as XOFLUZA, RAPIVAB, FLUAD QUADRIVALENT, mRNA-1010, CD388, Flu Pandemic mRNA (GSK4382276A), CC-42344, and others, are…
Type 1 Diabetes Market Outlook: TZIELD and Stem-Cell Breakthroughs Redefine Phar …
DelveInsight's comprehensive Type 1 Diabetes market analysis reveals significant growth potential through 2034, with the US commanding 89% market share. Key players include Eli Lilly, Sanofi, Novo Nordisk, Provention Bio, and 28+ other companies developing innovative therapies including TZIELD, REMD-477, and weekly insulins targeting 7MM patient population.
Type 1 Diabetes Key Takeaways
*
Type 1 Diabetes Market Size and Growth Projections: As per DelveInsight's analysis, the total market size of Type 1…
CinCor Pharma's Baxdrostat Demonstrates Promising Results in Phase III Trial for …
CinCor Pharma's baxdrostat has achieved statistically significant reductions in systolic blood pressure in patients with hard-to-control hypertension, according to positive full results from the BaxHTN Phase III trial announced on August 30, 2025. DelveInsight discusses the market impact and the changing competitive landscape on the Hypertension treatment market
CinCor Pharma's baxdrostat has achieved statistically significant and clinically meaningful reductions in systolic blood pressure in patients with hard-to-control hypertension, according to positive…
More Releases for Catheter
Midline Catheter Market
The midline catheter market plays a crucial role in healthcare, providing a safer and more effective means for intravenous (IV) therapies. Midline catheters are long, thin, flexible tubes that are inserted into a patient's veins, typically for periods ranging from a few days to a few weeks. They offer a minimally invasive alternative for administering medications, fluids, and nutrients directly into the bloodstream without the need for repeated needle sticks.…
Catheter Stabilization Devices Market
The "Catheter Stabilization Devices Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Catheter Stabilization Devices Market, 2024-2031
Verified Market Research's most recent report, "Catheter Stabilization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Catheter Stabilization Devices Market: Enhancing Patient Safety and Care through …
The Catheter Stabilization Devices Market occupies a pivotal position in the healthcare industry, providing essential solutions for securing catheters and enhancing patient care. As indwelling catheters become integral to various medical procedures and treatment protocols, the need for effective stabilization and securement is paramount. This market addresses this crucial requirement by offering a diverse range of devices designed to prevent catheter-related complications, including dislodgement and infection.
𝗧𝗼 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗺𝗮𝗿𝗸𝗲𝘁…
Catheter Introducer Sheaths Market - Safeguarding Vascular Health: Advanced Shea …
Newark, New Castle, USA: The "Catheter Introducer Sheaths Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Catheter Introducer Sheaths Market: https://www.growthplusreports.com/report/catheter-introducer-sheaths-market/8787
This latest report researches the industry structure,…
Catheter-related Blood Infections Market - Empowering Catheter Safety: Leading t …
Newark, New Castle, USA: The "Catheter-related Blood Infections Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Catheter-related Blood Infections Market: https://www.growthplusreports.com/report/catheterrelated-blood-infections-market/8671
This latest report researches the industry structure,…
Exclusive Report on Catheter Stabilization Devices Catheter Securement Devices M …
According to the study published by Evolve business intelligence, “The global Catheter Stabilization Devices Catheter Securement Devices market size is expected to reach $ Billion by 2028 growing at the CAGR of 15% from 2021 to 2028. The report provides the reader with a deep-dive understanding of business opportunities, competitor analysis, market size and forecast, go-to-market strategy, and market share. After evaluating the next-gen business analytic report, the reader is…
